Optimizing treatment for anal suppurations in Crohn's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify the best therapeutic strategies for achieving complete clinical and anatomical remission of anal suppurations in patients with Crohn's disease over a 12-month period. It will analyze various treatment combinations, including immunosuppressants, biotherapies, antibiotics, and surgical interventions, to determine their effectiveness. The study emphasizes the importance of MRI evaluations in assessing treatment responses and aims to redefine management protocols for patients with anoperineal lesions. By focusing on both medical and surgical approaches, the study seeks to improve patient outcomes and satisfaction.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Persons over 18 years of age
* People suffering from anal suppuration of Crohn's disease for whom a drainage procedure is planned.
* Person who has received written and oral information about the protocol and has not expressed opposition to participate in the study.

Exclusion Criteria:

* No one who is unable to have an anesthetic, structural or psychological examination by MRI and/or surgery.
* Person planning a planned absence that could hinder participation in the research (travel abroad, relocation, impending transfer);
* Person with an associated pathology that is a priority for care;
* Vulnerable person (minors, persons under guardianship or curatorship, or deprived of their liberty by a judicial or administrative decision

Where it's running

• Centre Hospitalier de Rennes
  Rennes, France Recruiting

Study contacts

• Principal investigator: Laurent SIPROUDHIS, PH-PD — Rennes University Hospital
• Study coordinator: kristell COAT
• Email: kristell.coat@chu-rennes.fr
• Phone: 299282555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Microencapsulated Propionate vs Butyrate for Crohn's Disease in Remission

  This study tests whether microencapsulated sodium propionate can favorably alter the gut microbiota and inflammation in adults with Crohn’s disease, compared with sodium butyrate.

  Recruiting University of Padova · Padova · NCT07883044

• Risankizumab for Refractory Perianal Fistulizing Crohn's Disease

  This study tests whether risankizumab can help people with Crohn’s disease who have draining perianal fistulas not responding to other treatments.

  Recruiting Phase 4 Hyogo Medical University · Nishinomiya and 3 other locations · NCT07872449

• Intestinal ultrasound-guided management for inflammatory bowel disease

  This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.

  Recruiting Mahidol University · Bangkok · NCT07775352

• Laser-based sizing of GI lesions during endoscopies

  This study tests whether the AccuMeasure laser tool gives more accurate and reliable lesion size measurements during colonoscopies for adults with colon polyps or Crohn’s disease than traditional endoscopic estimates.

  Recruiting Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT07770425

• A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis

  A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.

  Recruiting Catholic University of the Sacred Heart · Roma, RM · NCT07724990

• Claudin-2 Immunostaining to Detect Active or Inactive Inflammation in IBD Biopsies

  This study tests whether staining for Claudin-2 in intestinal biopsy samples can help identify active vs. inactive inflammation in people with ulcerative colitis or Crohn's disease.

  Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Mi · NCT07710287

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.